Illinois State Senate District 52 issued the following announcement on Oct. 29.
Unfair insulin costs are taking a toll on those who are forced to pay the excessive price for this life-saving prescription drug. State Senator Scott Bennett (D-Champaign) voted to change that Tuesday.
Senator Bennett co-sponsored Senate Bill 667, which would cap patients’ out-of-pocket costs at $100 for a 30-day supply.
“People with Type 1 and Type 2 diabetes need the medication,” Senator Bennett said. “Regular price hikes make insulin difficult to afford, and as lawmakers we have a responsibility to step in and protect the well-being of Illinoisans that depend on insulin.”
According to the American Diabetes Association, there are more than 30 million Americans who have diabetes, with 1.25 million having Type 1 diabetes. The condition requires daily administration of insulin to survive.
“This measure will provide financial relief to diabetics all across the state,” Bennett said. “The passage of this legislation is encouraging to continue to push for reform that will lower the cost of prescription drugs for everyone.”
Senate Bill 667 was spearheaded by State Senator Andy Manar (D-Bunker Hill).
The legislation has passed the Senate and now moves to the House of Representatives for consideration.
Original source can be found here.